PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,379,000 | -21.1% | 124,554 | +0.9% | 0.01% | -27.3% |
| Q1 2019 | $4,285,000 | +78.7% | 123,489 | +0.5% | 0.01% | +57.1% |
| Q4 2018 | $2,398,000 | -28.0% | 122,869 | -1.7% | 0.01% | -12.5% |
| Q3 2018 | $3,329,000 | -30.5% | 125,009 | -1.4% | 0.01% | -38.5% |
| Q2 2018 | $4,789,000 | +15.6% | 126,784 | 0.0% | 0.01% | +18.2% |
| Q1 2018 | $4,141,000 | -24.0% | 126,784 | +13.3% | 0.01% | -26.7% |
| Q4 2017 | $5,448,000 | -5.4% | 111,910 | +5.0% | 0.02% | -11.8% |
| Q3 2017 | $5,758,000 | -12.3% | 106,573 | -8.8% | 0.02% | -15.0% |
| Q2 2017 | $6,564,000 | +43.0% | 116,854 | -0.2% | 0.02% | +42.9% |
| Q1 2017 | $4,591,000 | +67.9% | 117,144 | -3.8% | 0.01% | +55.6% |
| Q4 2016 | $2,734,000 | +1.3% | 121,834 | +2.6% | 0.01% | 0.0% |
| Q3 2016 | $2,698,000 | +59.9% | 118,784 | +66.2% | 0.01% | +50.0% |
| Q2 2016 | $1,687,000 | +21.6% | 71,474 | +5.1% | 0.01% | +20.0% |
| Q1 2016 | $1,387,000 | -14.1% | 68,014 | +116.8% | 0.01% | -16.7% |
| Q4 2015 | $1,614,000 | +22.3% | 31,370 | +1.3% | 0.01% | +20.0% |
| Q3 2015 | $1,320,000 | -10.8% | 30,960 | -4.6% | 0.01% | 0.0% |
| Q2 2015 | $1,479,000 | +21.5% | 32,460 | +1.2% | 0.01% | +25.0% |
| Q1 2015 | $1,217,000 | +42.2% | 32,070 | +6.1% | 0.00% | +33.3% |
| Q4 2014 | $856,000 | +229.2% | 30,230 | +193.5% | 0.00% | +200.0% |
| Q3 2014 | $260,000 | -13.6% | 10,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $301,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |